The U.S. Department of Health and Human Services recently released the Substance Abuse and Mental Health Services Administration (SAMHSA) proposed regulation to modify 42 CFR Part 2, which governs the confidentiality of patient records for the treatment of substance use disorder (SUD). One of the major policy debates around 42 CFR Part 2 has been whether this set of regulations should be modified to align more closely with HIPAA, and the proposed regulation does not do so. Instead, SAMHSA proposes smaller modifications to 42 CFR Part 2 aimed at advancing care coordination for patients with SUD and clarifying existing policies for 42 CFR Part 2 treatment programs (federally assisted alcohol or drug abuse programs) and other health care providers. Visit the ACEP regulatory blog archive to catch up on all the latest news.
No Responses to “Patient Confidentiality for Substance Use Disorder”